MediFind
Condition

Spastic Paraplegia Type 5A

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: August 29, 2019
PCSK9 Inhibitor Treatment for Patients With Hereditary Spastic Paraplegia Type 5